spacer
home > white papers > Syringe siliconization - Gerresheimer AG
WHITE PAPERS
logo_Gerresheim1.jpg

Gerresheimer AG

phone +49-(0)211/61 81-00
email info@gerresheimer.com
web http://www.gerresheimer.com
email Klaus-Bungert-Str. 4, 40468 Duesseldorf, Germany

Syringe siliconization

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
spacer

Member login

E-mail address:

Password:
Remember me


News and Press Releases

Show germs the final curtain

Teknomek’s PVC strip curtains are renowned for helping reduce hygiene risk by keeping differently graded areas within cleanrooms separate. The company has now extended this protection by adding anti-microbial protection embedded within the PVC to prevent the growth of bacteria, including MRSA, and further minimising the risk of cross-contamination. The anti-microbial curtains are built to last, with silver ions incorporated during the manufacturing process, providing significantly greater microbial resistance. The hard-wearing curtains suitable for use in temperatures of +38°C to - 10°C.
More info >>


White Papers

Case Study: Getting the Client’s Trust - Oncology Program

Cmed Clinical Services

Five years ago, a biopharmaceutical company chose Cmed to conduct a phase II oncology study. Cmed’s performance of the study and the good relationship established with the Client led Cmed to be awarded a second oncology trial which a couple of years ago was followed by a third, fourth and fifth.
More info >>


Industry Events

14th Annual Biomarkers & Immuno-Oncology World Congress

11-13 June 2018, Westin Boston Waterfront, Boston, Massachusetts

The Biomarkers and Immuno-Oncology World Congress brings together a unique and international mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Congress a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>


©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement